[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 042″]
Transcend Medical CMO Sean Ianchulev provides an update on COMPASS trial and shares company’s plan for the FDA.
Sean Ianchulev, MD, MPH
Dr. Ianchulev is a physician-executive, innovator and venture capital investor with deep life-science and medical technology expertise. As an innovator he has been at the core of medical products and technologies which have transformed the ophthalmic practice.